HSPD1 and colorectal carcinoma: In regard to therapy resistance, the increased expression of HSP60 enhances the extent of cancer cell resistance to platinum analogs in human ovarian and bladder carcinoma cells, and, therefore, inhibition of HSP60 in 5-FU resistant SW480 CRC cells induces the attenuation of drug resistance [172].